|
699 Simvastatin
could become a pharmacy medicine within the next six months Simvastatin
could be available over the counter within six months, the Health Secretary
John Reid said earlier this week ...more
699 Statins
form part of the PAGB's draft OTC advertising guidance Advertising
of statins to the public is included in draft guidance on advertisements
for non-prescription medicines in new therapeutic indications, issued
by the Proprietary Association of Great Britain this week ...more
699 Supplementary
prescribing training on the way in Wales Application forms
for supplementary prescribing courses in Wales are being finalised and
are expected to be available next month ...more
700 New
regulation council opposes NHS proposals to create blame-free culture Opposition
to Department of Health proposals intended to create a blame-free culture
in the National Health Service, in order promote error reporting and
more rapid redress for patients who suffer harm, is being mounted by
the Council for the Regulation of Healthcare Professionals ...more
700 Seven-step
guide to improving patient safety launched by NPSA A seven-step
guide to improving patient safety has been launched by the National Patient
Safety Agency. The guide emphasises the need to create an open safety
culture and comes ahead of the national reporting and learning system,
to be launched by the NPSA shortly ...more
700 PSNC
hope for better funding in the future Hope exists that there
will be better funding for National Health Service pharmacy services
once a new contract is agreed, says the Pharmaceutical Services Negotiating
Committee ...more
701 Government's
way of changing control of entry is ultra vires, Numark claims The way the Government proposes to change control of entry regulations in England is “unlawful and ultra
vires”, Numark is saying after taking legal advice
...more
AHA conference
Reports
702 Atherosclerosis
progression halted by using intensive atorvastatin regimen Aggressive
lipid lowering with high-dose atorvastatin (Lipitor) can halt atherosclerosis
progression, researchers report ...more
702 Cultural
differences in compliance Differences in health outcomes between
African-American and Caucasian populations might be explained by differences
in compliance, researchers from the University of Pittsburgh, Pennsylvania,
suggested at the American Heart Association conference in Orlando, Florida,
last week ...more
702 Amiodarone
benefit for post-surgical AF Amiodarone is effective in preventing
atrial fibrillation after heart surgery, researchers reported at the
American Heart Association conference ...more
702 Adopting
guidelines does improve care A quality improvement programme
designed by the American Heart Association has been shown to improve
coronary care at 123 hospitals across the United States ...more
702 Weight
loss supplement concern The potential for America's leading
herbal product to cause arrhythmias was highlighted by a pharmacist,
Dr Brian McBride, University of Connecticut ...more
702 Start
statins in children with FH Children who have familial hypercholesterolaemia
should be given statins, say researchers ...more
702 No
benefit for combination Adding reteplase to abciximab is not
superior to abciximab alone in patients with acute myocardial infarction
undergoing balloon angioplasty ...more |
Other news
703 Studies indicate
when HIV therapy should start Decisions about when to initiate
antiretroviral therapy in children and adults infected with HIV will
be informed by data from two studies published earlier this week ...more
703 Yellow card
scheme is “chaotic and misconceived” The yellow
card scheme is chaotic and misconceived in some important respects, say
the authors of a new study ...more
703 Atorvastatin
benefit in diabetes Patients with diabetes and coronary heart
disease treated with atorvastatin (Lipitor) can expect to halve their
risk of a major vascular event ...more
703 Views sought
on nanotechnology Views on possible applications of nanotechnology
are being sought by the Royal Society and the Royal Academy of Engineering
...more
703 Olanzapine
for prevention of mania Olanzapine, the atypical antipsychotic,
(Zyprexa), is now licensed for the prevention of bipolar disorder recurrence
in patients whose manic episode has responded to treatment with olanzapine
...more
704 Leicester
students gain experience of practice in new audiovisual suite Pharmacy
students at De Montfort University, Leicester, are now honing their patient
counselling skills in a new £100,000 practice suite, officially
opened last week by John D'Arcy, chief executive of the National Pharmaceutical
Association ...more
704 Hospitals
to benefit from medicines management collaborative scheme Medicines
management collaboratives are to be established in hospitals in England
as the National Prescribing Centre seeks to extend the programme already
running in primary care ...more
704 Numark and
Nucare call off merger talks Numark Plc and Nucare Plc have
called off talks on a proposed merger between the two independent pharmacy
groups, saying that they were unable to agree on valuations of the two
companies ...more
704 Scopoderm
reclassification Novartis Consumer Health has asked the Medicines
and Healthcare products Regulatory Agency to reclassify Scopoderm TTS
(hyoscine 1.5mg transdermal patch) from a prescription only medicine
to a pharmacy medicine ...more
|
